Bain Capital Life Sciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $79,806.15 +4.84%
Ethereum $3,216.44 +6.17%
BNB $641.37 +3.47%
Optimism $1.72 +7.19%
Arbitrum $0.65 +8.37%
Solana $211.23 +7.25%
Polygon $0.41 +9.38%
Cosmos $5.40 +15.30%
Avalanche $32.53 +12.73%

Bitcoin $79,806.15 +4.84%
Ethereum $3,216.44 +6.17%
BNB $641.37 +3.47%
Optimism $1.72 +7.19%
Arbitrum $0.65 +8.37%
Solana $211.23 +7.25%
Polygon $0.41 +9.38%
Cosmos $5.40 +15.30%
Avalanche $32.53 +12.73%

Bain Capital Life Sciences

company

Investments

Number of Investments

Number of Lead Investments

10

5

Bain Capital Life Sciences has made 10 investments. Their most recent investment was on Nov 15, 2022, when Jnana Therapeutics, Inc raised

Date	Company Name	Round	Money Raised	Industry	Lead Investor
Nov 15, 2022	Jnana Therapeutics	Series C	—	Biotechnology	Yes
Sep 12, 2022	Nimbus Therapeutics	Series Unknown	—	Biotechnology	—
Jul 12, 2022	Areteia Therapeutics	Series A	—	Biotechnology	Yes
Jun 30, 2022	X4 Pharmaceuticals	Post-IPO Equity	—	Biotechnology	—
Dec 7, 2021	Freenome	Series D	—	Biotechnology	—
Mar 19, 2021	X4 Pharmaceuticals	Post-IPO Equity	—	Biotechnology	—
Aug 26, 2020	Freenome	Series C	—	Biotechnology	Yes
Dec 10, 2019	Marinus Pharmaceuticals	Post-IPO Equity	—	Biopharma	—
Sep 14, 2017	Marinus Pharmaceuticals	Post-IPO Equity	—	Biopharma	Yes
Sep 8, 2017	Replimune Group	Series B	—	Biotechnology	Yes